These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26964871)

  • 41. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
    Zhang Z; Liu X; Feng B; Liu N; Wu Q; Han Y; Nie Y; Wu K; Shi Y; Fan D
    Oncogene; 2015 Sep; 34(37):4808-20. PubMed ID: 25531324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
    Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
    J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
    Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
    Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
    Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
    Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.
    Dong J; Wang R; Ren G; Li X; Wang J; Sun Y; Liang J; Nie Y; Wu K; Feng B; Shang Y; Fan D
    Clin Cancer Res; 2017 Jul; 23(13):3461-3473. PubMed ID: 28119367
    [No Abstract]   [Full Text] [Related]  

  • 52. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging roles for HMGA2 in colorectal cancer.
    Wang X; Wang J; Wu J
    Transl Oncol; 2021 Jan; 14(1):100894. PubMed ID: 33069103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
    Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
    Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Wang Y; Sun N; Lu C; Bei Y; Qian R; Hua L
    Int J Oncol; 2017 Jun; 50(6):2191-2199. PubMed ID: 28498393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1.
    Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
    FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.
    Lam CS; Ng L; Chow AK; Wan TM; Yau S; Cheng NS; Wong SK; Man JH; Lo OS; Foo DC; Poon JT; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):26858-26870. PubMed ID: 28460469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.